Is rosuvastatin (Crestor) nephrotoxic? - UKidney.com
Links shared publicly online about this topic.
- 556total visits
Is rosuvastatin (Crestor) nephrotoxic? - UKidney.com
View full resource at ukidney.com
Tags: Heart Disease, Cholesterol Medication, High Blood Pressure, Kidney Health, Urinary System, Crestor, Nephrology, Education
Most Recently Shared on January 25, 2011 at 3:47 am By:
RT @UKidney: Is rosuvastatin (Crestor) nephrotoxic? http://t.co/sriIIYv
Statin drug linked to lower pneumonia risk - Yahoo! News
news.yahoo.com — “From Yahoo! News: NEW YORK (Reuters Health) - People who use cholesterol-lowering statins may have a slightly lower risk of developing pneumonia than non-users do, a study out Monday concludes. Israeli researchers found that of nearly 18,000 adults in a clinical trial of rosuvastatin (Crestor), those given the drug were 17 percent less likely to develop pneumonia over several years, versus people given a placebo. That's a small effect, and no one is suggesting people start on statins in the hope” View full resource at news.yahoo.com
Most Recently Shared on March 19, 2012 at 10:08 pm By:
Statin drug linked to lower pneumonia risk: NEW YORK (Reuters Health) - People who use cholesterol-lowering stat... http://t.co/s2tsrIpj
Statins May Lower Pneumonia Risk - ABC News
abcnews.go.com — “Statins, the same drugs that help millions of Americans control their cholesterol may also help prevent pneumonia, a new study found. Blocking cholesterol build-up inside arteries, statins reduce the risk of heart disease. But a clinical trial of Crestor, made by the London-based drug company AstraZeneca, suggests the benefits of statins extend beyond the heart. “Participants randomly assigned to receive rosuvastatin [Crestor is the brand name] had a modest reduction in the” View full resource at abcnews.go.com
Most Recently Shared on March 19, 2012 at 10:08 pm By:
Statins May Lower Pneumonia Risk: Statins, the same drugs that help millions of Americans control their choleste... http://t.co/zpqrdxzL
Statin drug linked to lower pneumonia risk - Yahoo! News
news.yahoo.com — “From Yahoo! News: NEW YORK (Reuters Health) - People who use cholesterol-lowering statins may have a slightly lower risk of developing pneumonia than non-users do, a study out Monday concludes. Israeli researchers found that of nearly 18,000 adults in a clinical trial of rosuvastatin (Crestor), those given the drug were 17 percent less likely to develop pneumonia over several years, versus people given a placebo. That's a small effect, and no one is suggesting people start on statins in the hope” View full resource at news.yahoo.com
Most Recently Shared on March 19, 2012 at 6:41 pm By:
HealthTrendster Health Executive
Statin drug linked to lower pneumonia risk - NEW YORK (Reuters Health) - People who use cholesterol-lowering statins... http://t.co/YMdd9YNL
Mylan Canada Receives Health Canada Approval for Generic Version of Crestor - Drugs.com MedNews
drugs.com — “Mylan Pharmaceuticals ULC, the Canadian subsidiary of Mylan Inc. (NASDAQ MYL), today received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets” View full resource at drugs.com
Most Recently Shared on March 15, 2012 at 10:06 pm By:
Drugs and Devices OW OW Health
Mylan Canada Receives Health Canada Approval for Generic Version of Crestor: PITTSBURGH and TORONTO, March... http://t.co/FZWSiuO5 #drug
Not all statins equal in patients with acute coronary syndrome - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – The lipid-modifying effects of rosuvastatin (Crestor: AstraZeneca) are stronger than atorvastatin (Lipitor; Pfizer) in patients with an acute coronary syndrome (ACS), according to new data from the LUNAR Trial. Patients with ACS are recommended for...” View full resource at thedoctorschannel.com
Most Recently Shared on March 13, 2012 at 6:16 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
Learn more about which statin is more effective! - From Reuters Health/TDC http://t.co/bFlDPMxc #ACS #health #heart #rosuvastatin #statins
AHA: Crestor, Lipitor both shine in high-dose SATURN trial
cardiovascularbusiness.com — “Both rosuvastatin (Crestor, AstraZeneca) and atorvastin (Lipitor, Pfizer) at maximum dose lowered LDL cholesterol levels, raised HDL levels and reduced atherosclerotic plaque in the SATURN trial, the study’s lead researcher reported Nov. 15 at the 2011 American Heart Association (AHA) conference. While the Phase 2 clinical trial failed to find any significant difference between the two drugs’ ability to limit or reverse progression of coronary artery disease, it showed that a high-dose regime is” View full resource at cardiovascularbusiness.com
Most Recently Shared on November 15, 2011 at 7:30 pm By:
CardioBusiness Health Magazine
AHA: Crestor, Lipitor both shine in high-dose SATURN trial - Both rosuvastatin (Crestor, AstraZeneca) and atorvastin... http://t.co/G33Z7rDo
Medical News: SATURN Statin Trial a Dead Heat - in Cardiovascular, Atherosclerosis from MedPage Today
medpagetoday.com — “Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor) for improving atheroma volume in a large head-to-head trial, the drug's manufacturer reported.” View full resource at medpagetoday.com
Most Recently Shared on September 5, 2011 at 5:32 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: SATURN Statin Trial a Dead Heat - http://t.co/2CGAMXv from @medpagetoday #health #medicine
Manage Account - ModernMedicine
modernmedicine.com — “LONDON/ZURICH (Reuters) - AstraZeneca's key cholesterol drug Crestor (rosuvastatin) failed to beat Pfizer Inc's Lipitor (atorvastatin) in a head-to-head clinical study.” View full resource at modernmedicine.com
Most Recently Shared on September 4, 2011 at 7:18 am By:
Astra's Crestor drug fails to beat Pfizer's Lipitor: LONDON/ZURICH (Reuters) - AstraZeneca's key cholesterol dru... http://t.co/OaLA25E
Rosuvastatin Fails to Best Atorvastatin in IVUS Study of Atherosclerosis Progression - Forbes
forbes.com — “AstraZeneca announced today that its lipid-lowering agent rosuvastatin (Crestor) was not superior to atorvastatin (Lipitor, Pfizer) in reducing the progression of atherosclerosis as assessed by IVUS. The company announced the top-line results of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN), which is scheduled to be [...]” View full resource at forbes.com
Most Recently Shared on September 2, 2011 at 11:25 pm By:
Drugs and Devices OW OW Health
Rosuvastatin Fails to Best Atorvastatin in IVUS Study of Atherosclerosis Progression: AstraZeneca annou... http://t.co/c0y6V2E #drug
Crestor, after setback in Lipitor trial, may take sales hit - Medical Marketing and Media
mmm-online.com — “AstraZeneca's top-selling product, Crestor (rosuvastatin), is looking shaky after results from SATURN, a head-to-head study pitting the statin against Pfizer's soon-to-go-generic Lipitor (atorvastatin), were released today, leaving the $5.7 billion drug bereft of superior efficacy boasting rights.” View full resource at mmm-online.com
Most Recently Shared on September 2, 2011 at 7:21 pm By:
Crestor, after setback in Lipitor trial, may take sales hit: AstraZeneca's top-selling product, Cresto... http://t.co/0gY19h7 from MM&M
Medical News: SATURN Statin Trial a Dead Heat - in Cardiovascular, Atherosclerosis from MedPage Today
medpagetoday.com — “Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor) for improving atheroma volume in a large head-to-head trial, the drug's manufacturer reported.” View full resource at medpagetoday.com
Most Recently Shared on September 2, 2011 at 7:07 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: SATURN Statin Trial a Dead Heat - http://t.co/fcaxC3g from @medpagetoday #health #medicine
Medical News: SATURN Statin Trial a Dead Heat - in Cardiovascular, Atherosclerosis from MedPage Today
medpagetoday.com — “Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor) for improving atheroma volume in a large head-to-head trial, the drug's manufacturer reported.” View full resource at medpagetoday.com
Most Recently Shared on September 2, 2011 at 4:07 pm By:
Patricia Grace Eldercare Expert
SATURN Statin Trial a Dead Heat: (MedPage Today) -- Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor)... http://t.co/P23nqHz
SATURN Statin Trial a Dead Heat - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor) for improving atheroma volume in a large head-to-head trial, the drug's manufacturer reported.” View full resource at qualitypointtech.net
Most Recently Shared on September 2, 2011 at 3:45 pm By:
SATURN Statin Trial a Dead Heat: (MedPage Today) -- Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor) f... http://t.co/L9dDpr7
Medical News: SATURN Statin Trial a Dead Heat - in Cardiovascular, Atherosclerosis from MedPage Today
medpagetoday.com — “Rosuvastatin (Crestor) failed to beat atorvastatin (Lipitor) for improving atheroma volume in a large head-to-head trial, the drug's manufacturer reported.” View full resource at medpagetoday.com
Most Recently Shared on September 2, 2011 at 3:18 pm By:
SATURN Statin Trial a Dead Heat http://t.co/d4dFJZk
Coronary Artery Calcium Might Help Identify Low-Risk Patients Who Would Benefit from Statins - General Medicine
general-medicine.jwatch.org — “In the placebo-controlled JUPITER trial (JW Gen Med Nov 18 2008), rosuvastatin (Crestor) significantly lowered the incidence of adverse cardiovascular events in healthy patients with normal levels of LDL cholesterol (<130 mg/dL) and . . .” View full resource at general-medicine.jwatch.org
Most Recently Shared on August 31, 2011 at 1:27 pm By:
Juliet Mavromatis Doctor, Internist, and Physician
On the fence about treating your cholesterol with medicine ? A coronary artery calcium determination might help... http://t.co/OOldWkm
Advertisement
